{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Promising Results for Combined Therapy in Unresectable Esophageal Cancer

Activity Steps

1 Activity
2 Take Test 3Certificate

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Discuss the potential efficacy of conversion chemoradiotherapy (CRT) followed by immunochemotherapy (iCT) in patients with unresectable esophageal squamous cell carcinoma (ESCC).
  2. Evaluate the safety of the combined therapy.

Learning Outcomes

By the conclusion of this activity, a majority of the participants will demonstrate knowledge of a phase II study demonstrating the safety and potential efficacy of conversion chemoradiotherapy (CRT) followed by immunochemotherapy (iCT) in patients with unresectable, locally advanced esophageal cancer by achieving a passing score on the posttest.

Disclosures

All authors, faculty, staff, and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH
  • NM - BON 1.0 CH
  • SC - BON 1.0 CH
  • WV - BOERN 1.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Planner
Test Code: OT0225
Published: February 2025
Expires: 3/5/2027
Sources: Oncology Times
Required Passing Score: 4/5 (80%)
Authors: Catlin Nalley
Categories: Cancer , Drug Therapy , Gastrointestinal , Oncology
Specialties: Gastroenterology, Oncology, Radiology
Topics: Chemoradiation , Chemotherapy , Disorders , Esophageal Cancer , Radiation Therapy